Delisting riskPopularity #4,929
Lifeward (LFWD)
Powered exoskeletons and anti-gravity treadmills for mobility and rehabilitation.
$6.99
After hours−0.14 (−1.96%)
At close$7.13(+1.78%)
In millions of USD, except per-share figures
| In millions | Q3 FY23Sep 2023 | Q4 FY23Dec 2023 | Q1 FY24Mar 2024 | Q2 FY24Jun 2024 | Q3 FY24Sep 2024 | Q4 FY24Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4 | 7 | 5 | 7 | 6 | 8 | 5 | 6 | 6 | 5 | 4 | 7 |
| Cost of revenue | 4 | 4 | 4 | 4 | 4 | 6 | 3 | 3 | 3 | 4 | 3 | 4 |
| Gross profit | 1 | 2 | 1 | 3 | 2 | 2 | 2 | 3 | 3 | 1 | 1 | 3 |
| 9 | 9 | 8 | 7 | 5 | 11 | 7 | 9 | 6 | 6 | 12 | 7 | |
| Research & development | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 6 | 2 |
| 8 | 7 | 7 | 6 | 4 | 6 | 6 | 6 | 5 | 5 | 6 | 5 | |
| Selling & marketing | 4 | 5 | 5 | 4 | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 4 |
| General & administrative | 3 | 2 | 2 | 2 | 0 | 2 | 2 | 2 | 2 | 2 | 3 | 2 |
| Other expenses | 0 | 0 | 0 | 0 | 0 | 4 | 0 | 3 | 0 | 0 | 0 | 0 |
| Operating income | −8 | −6 | −7 | −4 | −3 | −10 | −5 | −7 | −3 | −5 | −10 | −4 |
| 0 | 0 | 0 | 0 | −3 | −6 | 0 | −7 | 0 | 0 | 0 | −7 | |
| Interest income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other non-operating income | 0 | 0 | 0 | 0 | 3 | −4 | 0 | −3 | 0 | 0 | 0 | 7 |
| Income before tax | −8 | −6 | −6 | −4 | −6 | −15 | −5 | −13 | −3 | −5 | −11 | −12 |
| Income tax expense | 0 | 0 | 0 | 0 | −3 | 0 | 0 | −7 | 0 | 0 | 0 | 0 |
| Net income from continuing operations | −8 | −6 | −6 | −4 | −3 | −15 | −5 | −7 | −3 | −5 | −11 | −12 |
| Net income | −8 | −6 | −6 | −4 | −3 | −15 | −5 | −7 | −3 | −5 | −11 | −12 |
| EPS, basic | −$10.56 | −$10.92 | −$8.76 | −$6.00 | −$4.20 | −$20.76 | −$5.52 | −$6.96 | −$2.40 | −$3.60 | −$6.70 | −$4.12 |
| EPS, diluted | −$10.56 | −$10.92 | −$8.76 | −$6.00 | −$4.20 | −$20.76 | −$5.52 | −$6.96 | −$2.40 | −$3.60 | −$6.70 | −$4.12 |
| Weighted average shares, basic | 1 | — | — | — | — | — | — | — | 1 | 1 | 2 | 3 |
| Weighted average shares, diluted | 1 | — | — | — | — | — | — | — | 1 | 1 | 2 | 3 |
| EBITDA | −7 | −5 | −5 | −3 | −5 | −4 | −5 | −4 | −3 | −5 | −5 | −11 |
| Depreciation & amortization | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 5 | 0 |
| EBIT | −8 | −6 | −6 | −4 | −6 | −5 | −5 | −4 | −3 | −5 | −10 | −11 |
